Data / Drug companies / Bavarian Nordic A/s
Bavarian Nordic A/s: 10 products in the FDA NDC directory, labeler code 50632
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bavarian Nordic A/s (labeler code 50632) lists 10 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 10 vaccines. Its main marketing category is biologics (BLA). The newest product started marketing on December 31, 2025.
The request: Watch Bavarian Nordic A/s (FDA labeler code 50632): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50632
- Products in commercial distribution
- 10
- Packages
- 11
- Finished drugs by generic name
- 5
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- November 11, 1997
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Biologics (BLA) | 10 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Vaccines | 10 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Water for injection | 1 | 1 |
| Chikungunya vaccine, recombinant | 1 | 1 |
| Salmonella typhi ty21a | 1 | 1 |
| Rabies vaccine | 1 | 1 |
| Cholera vaccine, live, oral | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, suspension | 4 | 40% |
| Injection, powder, lyophilized, for suspension | 2 | 20% |
| Kit | 2 | 20% |
| Liquid | 1 | 10% |
| Capsule, coated | 1 | 10% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Live Attenuated Salmonella Typhi Vaccine | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Jynneos | 50632-024 | Injection, powder, lyophilized, for suspension | Biologics (BLA) | December 31, 2025 |
| Diluent Component | 50632-003 | Liquid | Biologics (BLA) | April 14, 2025 |
| Jynneos | 50632-002 | Injection, powder, lyophilized, for suspension | Biologics (BLA) | April 14, 2025 |
| Vimkunya | 50632-018 | Injection, suspension | Biologics (BLA) | March 1, 2025 |
| Jynneos | 50632-023 | Injection, suspension | Biologics (BLA) | February 14, 2025 |
| Jynneos | 50632-022 | Injection, suspension | Biologics (BLA) | February 14, 2025 |
| Vivotif | 50632-016 | Capsule, coated | Biologics (BLA) | July 1, 2024 |
| Vaxchora | 50632-015 | Kit | Biologics (BLA) | June 1, 2024 |
| Jynneos | 50632-001 | Injection, suspension | Biologics (BLA) | March 17, 2021 |
| RabAvert | 50632-010 | Kit | Biologics (BLA) | November 11, 1997 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.